SPL 2.11% 9.3¢ starpharma holdings limited

Ann: SPL7013 shows potent antiviral activity in RSV, page-18

  1. 114 Posts.
    lightbulb Created with Sketch. 10
    I'm on the fence about SPL's selling ability.
    I'm beginning to understand that management have a focus on science, not monetization.
    I think SPL's product line would best reach the market if they sold the finished products to another company.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
-0.002(2.11%)
Mkt cap ! $38.35M
Open High Low Value Volume
9.5¢ 9.5¢ 9.3¢ $48.64K 512.2K

Buyers (Bids)

No. Vol. Price($)
3 153365 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.